Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Patricia Obregon"'
Autor:
Patricia Obregon, Pascal M. W. Drake, Julian K.-C. Ma, Daniel Chargelegue, Nicholas D. Vine, Craig J. van Dolleweerd
Publikováno v:
Plant Molecular Biology. 52:233-241
The secretion of a functional, full-length monoclonal antibody complex from transgenic Nicotiana tabacum roots has been demonstrated. Initially, seeds were germinated on nitrocellulose membranes and antibody secretion detected from the developing roo
Autor:
Julian K.-C. Ma, Craig J. van Dolleweerd, Nicholas D. Vine, Daniel Chargelegue, Pascal M. W. Drake, Patricia Obregon
Publikováno v:
The FASEB Journal. 16:1855-1860
The feasibility of using antibody expressing transgenic plants either to neutralize bioactive molecules in the rhizosphere, or to accumulate and concentrate the molecules in leaves has been demonstrated in a model system consisting of hydroponic Nico
Autor:
James Nuttall, Daniel Chargelegue, Patricia Obregon, Lorenzo Frigerio, Julian K.-C. Ma, Alessandra Prada, Pascal M. W. Drake
Publikováno v:
Plant biotechnology journal. 4(2)
We describe the engineering of a human immunodeficiency virus-1 (HIV-1) p24-immunoglobulin A (IgA) antigen-antibody fusion molecule for therapeutic purposes and its enhancing effect on fused antigen expression in tobacco plants. Although many recombi
Autor:
Patricia Obregon, Alessandra Prada, Julian K.-C. Ma, Daniel Chargelegue, Neil F. Fairweather, Pascal M. W. Drake
Vaccine development has been hampered by difficulties in developing new and safe adjuvants, so alternative technologies that offer new avenues forward are urgently needed. The goal of this study was to express a monoclonal recombinant immune complex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35e9562bdfe21841926376c7b3488635
https://europepmc.org/articles/PMC1231086/
https://europepmc.org/articles/PMC1231086/
Publikováno v:
Molecular Farming: Plant-Made Pharmaceuticals and Technical Proteins
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8caf97f5650d11cd31ecd85fc2096da4
https://doi.org/10.1002/3527603638.ch10
https://doi.org/10.1002/3527603638.ch10
Publikováno v:
Vaccine. 23(15)
The use of transgenic plants for the production of recombinant proteins is not a universal solution for all proteins. The choice of this expression system depends very much on the type of protein and its applications. Many proteins will best be made
Autor:
Pascal M W, Drake, Daniel M, Chargelegue, Nicholas D, Vine, Craig J, van Dolleweerd, Patricia, Obregon, Julian K C, Ma
Publikováno v:
Plant molecular biology. 52(1)
The secretion of a functional, full-length monoclonal antibody complex from transgenic Nicotiana tabacum roots has been demonstrated. Initially, seeds were germinated on nitrocellulose membranes and antibody secretion detected from the developing roo
Autor:
Patricia Obregon, Julian K.-C. Ma, Daniel Chargelegue, Alessandra Prada, Pascal M. W. Drake, Lorenzo Frigerio
Publikováno v:
Plant Biotechnology 2002 and Beyond ISBN: 9789048162208
There is increasing interest in transgenic plant technology for the production of a wide range of recombinant proteins for pharmaceutical and industrial uses. There are many potential benefits in using plants as bioreactors for the production of such
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb4912637e29ad009e440ec147be5204
https://doi.org/10.1007/978-94-017-2679-5_75
https://doi.org/10.1007/978-94-017-2679-5_75
Publikováno v:
Trends in Plant Science. 6:495-496
The expression of antigens in vegetables and fruits has opened up a new avenue for the development of oral vaccines. In a recent report, an oral multi-component vaccine comprising a viral and a bacterial antigen has been successfully designed and has
Autor:
Luis M. Bedoya, Manuela Beltrán, Javier García-Pérez, Patricia Obregón-Calderón, Oliver Callies, Ignacio A. Jímenez, Isabel L. Bazzocchi, José Alcamí
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Current research on antiretroviral therapy is mainly focused in the development of new formulations or combinations of drugs belonging to already known targets. However, HIV-1 infection is not cured by current therapy and thus, new approaches are nee
Externí odkaz:
https://doaj.org/article/6d2e36e7b57e4efd8a160bf22fc16676